GLENMARK

Glenmark Pharmaceuticals

₹1,541.65
+0.85 (0.06%)
  • Advice
  • Hold
22 December, 2024 07:04 BSE: 532296 NSE: GLENMARKISIN: INE935A01035

Start SIP in Glenmark Pharmaceuticals

Start SIP

Glenmark Pharmaceuticals Performance

Day Range

₹ 1,541

52 Week Range

₹ 1,541

Glenmark Pharmaceuticals Share Price

  • Over 1 Month +5.13%
  • Over 3 Month -5.81%
  • Over 6 Month +25.28%
  • Over 1 Year +87.18%

Glenmark Pharmaceuticals Key Statistics

Glenmark Pharmaceuticals Technicals

EMA & SMA

Current Price
₹1,541.65
+0.85 (0.06%)
pointer
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • ₹1,541.10
  • 50 Day
  • ₹1,575.85
  • 100 Day
  • ₹1,546.03
  • 200 Day
  • ₹1,397.32
  • 20 Day
  • ₹1,529.78
  • 50 Day
  • ₹1,612.34
  • 100 Day
  • ₹1,623.38
  • 200 Day
  • ₹1,373.40

Glenmark Pharmaceuticals Resistance and Support

PIVOT
₹1,544.14
Resistance
First Resistance 1,558.22
Second Resistance 1,574.78
Third Resistance 1,588.87
RSI 48.06
MFI 42.47
MACD Single Line -22.98
MACD -16.13
Support
First Support 1,527.57
Second Support 1,513.48
Third Supoort 1,496.92

Glenmark Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 653,660 33,003,293 50.49
Week 513,746 18,166,044 35.36
1 Month 688,467 26,795,152 38.92
6 Month 927,070 40,939,401 44.16

Glenmark Pharmaceuticals Result Highlights

Glenmark Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Glenmark Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Quarterly Results
2024-05-24 Audited Results & Final Dividend
2024-02-14 Quarterly Results
2023-11-10 Quarterly Results

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91